Press Releases
-
RealTime-CTMS Introduces a Powerful, No-Cost Custom Reporting Tool Into All CTMS Products
RealTime Software Solutions, LLC has released the inSITES Report Builder, a powerful custom reporting tool built into RealTime’s leading Clinical Trial Management System (CTMS) that now allows all customers, at no additional charge, to build and save their own customized reports to monitor site-wide performance and maximize efficiencies and outcomes.
Feb 8, 2022
-
LogiPharma leads the way as Tower takes cold chain containers on the road
About Tower www.towercoldchain.com Tower delivers proven physical and temperature protection for pharmaceutical and life science products and our robust, reliable and reusable containers are the essential link in the stability of the cold chain. Headquartered in the UK, we operate a global network ensuring availability and easy access to our products for all customers. We are trusted by global pharmaceutical, logistics and airline companies and our experienced team, supported by a centralised quality-management system, reinforces customer confidence that our shipping facilities will meet requirements throughout the supply chain. Our patented design technology ensures our solutions meet the pharmaceutical industry performance standard, providing a minimum of 120 hours temperature compliance in any environment, anywhere in the world. We work closely with our customers, realising their requirements and how we can address emerging needs. and to deliver customer-focused innovation in temperature-controlled protection. For Tower sales enquiries please contact: Nick Gilmore, Global Head of Sales & Marketing Email: Nick.Gilmore@towercoldchain.com For Tower media enquiries please contact: Simon Kinnear or Rhiannon Hopper, Nielsen McAllister Tel: +44 (0)1332 293939 Email: tower@nmpr.co.uk
Jan 30, 2022
-
INCOG BioPharma Services builds state-of-the-art facility with promise to deliver a better customer experience
-
ArisGlobal Closes 2021 with Tremendous Growth Across Customer Base, Talent, and Revenue, Further Solidifying Its Leadership in Life Sciences R&D Software
Life sciences technology pioneer delivers record bookings and double-digit increase in revenue; Gears up for the future with investments in LifeSphere SaaS platform
Jan 12, 2022
-
BOC Sciences Provides PseudoUridines for Vaccine R&D
-
Alfa Chemistry Releases Functional PEGs for Biological and Therapeutic Research
-
Protection Reagents Optimized to Facilitate Organic Synthesis at Alfa Chemistry
-
Rho Promotes Mark Ubert to CFO
Rho, a full-service contract research organization (CRO) with a proven track record of drug development success, has promoted Mark Ubert, MBA, to the position of Chief Financial Officer (CFO). As CFO, Mark will provide financial and strategic leadership to the growing organization, exemplified in the role he played in Rho’s acquisition of European CRO Dokumeds. Mark brings more than 30 years of experience to the role of Chief Financial Officer. He joined Rho in March of 2020 as VP of Finance.
Jan 16, 2022
-
Dolomite Bio announce launch of cost-effective Bioinformatics service with brand new RNAdia kit for single cell research
Dolomite Bio has announced the launch of a Bioinformatics Service which can be purchased alongside the recently launched RNAdia kit for single-cell research.
Jan 18, 2022
-
Flourish Research Adds Great Lakes Clinical Trials and Clinical Site Partners to the Network, Tripling Revenue and Expanding Clinical Expertise in Six Months
Great Lakes Clinical Trials and Clinical Site Partners join Excel Medical Clinical Trials and platform site Clinical Trials of Texas at Flourish Research, expanding capabilities to 60 indications.
Jan 19, 2022
-
Improved Image Quality and Resolution for all ZEISS Laser Scanning Microscopes
ZEISS LSM Plus and ZEISS Airyscan Joint Deconvolution introduced
Jan 19, 2022
-
Creative Bioarray Provides Reliable and Consistent FBS Products to Faciliatate The Research of Cell Culture
-
Creative Bioarray Launches A Wide Range of FISH Services to Support Detecting RNA and DNA Sequences
-
Histobiolab Has Developed Professional Tissue Microarray to Meet Precise Research Needs
-
Creative Biogene Provides Reliable and High Quality Pseudovirus Services to Support The Studies of SARS-CoV-2
-
Qvirus Platform Designed Customized AAV Testing Services to Accelerate The Development of Viral Vaccine and Gene Therapy
-
Microbiosci Provides Comprehensive Service for Pichia Pastoris Fermentation to Process Development of Microbiological Research
-
CD Formulation: Customized Preparation of Active Pharmaceutical Ingredient Excipients to Accelerate Drug Formulation Projects
-
Quantum Dots & Upconverting Nanoparticles Provided by Alfa Chemistry Can Improve Medical Technology and Energy Research
-
Microarray Data Analysis Service Now Available by CD Genomics's Bioinformatics-Analysis Platform
The Bioinformatics-analysis division is a new division of CD Genomics that provides reliable next-generation and third-generation high-throughput sequencing data analysis, comprehensive technology services, database construction, and other related data analysis services. Recently, CD Genomics announced the launch of the Microarray Data Analysis service to help scientists discover the biological significance of microarray data and, at the same time, help reduce the time and cost of wet laboratory experiments and data generation.
Jan 17, 2022